2 Top Quantum Computing Stocks to Buy in July

IonQ, a pure-play quantum computing company, reported a $331.6 million net loss on $43.1 million revenue last year but maintains a strong $1.7 billion cash position and differentiates with its high-fidelity trapped-ion technology, securing key government contracts. Concurrently, IBM, a long-standing quantum pioneer, plans a $30 billion investment into the sector, aiming for quantum advantage by 2026 and fault-tolerant systems by 2029, bolstered by its $14.5 billion Q1 2025 revenue and $17.6 billion cash reserves. These firms represent distinct approaches to investing in the nascent, high-growth potential quantum computing market, projected to reach $1.3 trillion by 2035.

Analysis

The quantum computing sector presents a high-growth but speculative investment landscape, with IonQ and IBM representing two distinct strategic approaches. IonQ (IONQ) operates as a high-risk, pure-play entity, distinguished by its unique trapped-ion technology which recently achieved over 99.9% fidelity, a significant technical milestone. Despite nearly doubling its revenue to $43.1 million last year, the company remains unprofitable with a net loss of $331.6 million, though its financial runway is substantial with nearly $1.7 billion in cash. Key validation comes from contracts with the U.S. Air Force Research Lab and the Department of Defense. In contrast, International Business Machines (IBM) offers a more stable, diversified entry point. As an established technology leader, IBM is leveraging its significant financial strength, evidenced by its $14.5 billion in Q1 2025 revenue and $17.6 billion in cash reserves, to fund a massive $30 billion investment in quantum and mainframe development. IBM has an ambitious roadmap aiming for quantum advantage by 2026 and fault-tolerant systems by 2029. While its shares have gained 29% this year, the stock trades at a reasonable valuation of less than 27 times adjusted forward earnings, providing exposure to the quantum theme within a profitable and diversified corporate structure.

Key Decisions for Investors

• Investors with a high-risk tolerance seeking pure-play exposure to a differentiated quantum technology could consider IonQ, but must underwrite the risk of unprofitability until a projected 2030 timeframe.
• For more conservative investors, IBM provides exposure to the quantum sector's upside potential, supported by a strong balance sheet, diversified revenue streams, and a clear technology roadmap, making it a lower-beta alternative.
• Key metrics to monitor for IonQ include its cash burn rate relative to its $1.7 billion reserve and the securing of further high-profile commercial or government contracts as validation of its platform.
• For IBM, investors should track the company's progress against its development milestones, particularly the targeted demonstration of quantum advantage in 2026, which could serve as a major valuation catalyst.
• Given the nascent and uncertain nature of the quantum industry, any allocation to these stocks should be sized appropriately within a diversified portfolio to mitigate sector-specific risks.